The Pennsylvania Commonwealth Universal Research Enhancement Program, also known as CURE, was established in 2001 by Act 77, funded by the tobacco settlement. The funds from this state program flow from the Pennsylvania Department of Health and are intended to support broad-based research, in addition to research related to tobacco use.

CHOP researchers, including Stephan A. Grupp, MD, PhD, have been recipients of CURE funds for a number of years. In fact, Dr. Grupp credits CURE dollars with contributing to his breakthrough research on treating pediatric leukemia with T-cell therapy, which is now approved by the FDA.

The Government Affairs team at Children's Hospital of Philadelphia (CHOP) advocates annually at the state level for the CURE Program. To learn more about our state level advocacy, please contact our Government Affairs team.